We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Cambridge, UK-based Crescendo Biologics will expand its discovery and development collaboration with Japanese pharma company Takeda, which is focused on building Humabody-based therapeutics against undisclosed targets.